U.S. Government Cuts Funding and Contracts for Moderna's Bird Flu Vaccine Development
TL;DR Summary
The US Department of Health and Human Services canceled a $590 million contract with Moderna for developing H5 avian flu vaccines, raising concerns among health experts about preparedness for potential bird flu pandemics, despite Moderna's positive clinical trial results and the company's plans to explore alternative development options.
- HHS cancels funding for Moderna’s candidate H5 avian flu and pandemic vaccines CIDRAP
- U.S. Cancels Contract With Moderna to Develop Bird Flu Vaccine The New York Times
- Trump administration cancels plans to develop a bird flu vaccine NPR
- HHS slams 'under-tested' mRNA technology as Trump cuts Moderna's vaccine funding Fox News
- Moderna suffers a $750 million loss from NIH funding cut Yahoo Finance
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
91%
547 → 48 words
Want the full story? Read the original article
Read on CIDRAP